Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Relapse Prevention”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableUnknownNCT02221635
What this trial is testing

Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective

Who this might be right for
Schizoaffective Disorder
Xijing Hospital 540
Post-approval studies (Phase 4)Study completedNCT00848432
What this trial is testing

Risperidone Maintenance Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Capital Medical University 404
Not applicableStudy completedNCT01202617
What this trial is testing

Seroquel XR in the Long Term Treatment of Schizophrenia

Who this might be right for
Relapse in Schizophrenia
AstraZeneca 1,606
Not applicableUnknownNCT01936220
What this trial is testing

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

Who this might be right for
Schizophrenia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 200
Large-scale testing (Phase 3)Study completedNCT00150176
What this trial is testing

To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)

Who this might be right for
Schizophrenia
Organon and Co 831
Large-scale testing (Phase 3)Study completedNCT01291511
What this trial is testing

Relapse Prevention Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 635
Large-scale testing (Phase 3)Study completedNCT01529515
What this trial is testing

Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 509
Large-scale testing (Phase 3)Looking for participantsNCT07686263
What this trial is testing

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 472
Large-scale testing (Phase 3)Ended earlyNCT03593213
What this trial is testing

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 587
Large-scale testing (Phase 3)Study completedNCT01662310
What this trial is testing

An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 201
Large-scale testing (Phase 3)Study completedNCT01193153
What this trial is testing

Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Janssen Scientific Affairs, LLC 667
Not applicableStudy completedNCT02819349
What this trial is testing

Texting for Relapse Prevention

Who this might be right for
SchizophreniaSchizoaffective Disorder
Center for Innovative Public Health Research 40
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Post-approval studies (Phase 4)Ended earlyNCT00946985
What this trial is testing

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Who this might be right for
Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC 163
Post-approval studies (Phase 4)Study completedNCT00621777
What this trial is testing

Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
Massachusetts General Hospital 247
Not applicableStudy completedNCT00990626
What this trial is testing

Seroquel XR in Schizophrenia Relapse Prevention

Who this might be right for
Schizophrenia Relapse Prevention
AstraZeneca 1,600
Not applicableUnknownNCT00161408
What this trial is testing

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

Who this might be right for
Schizophrenic Disorders
University Hospital Tuebingen 106
Post-approval studies (Phase 4)Study completedNCT00320697
What this trial is testing

Smoking Relapse Prevention in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSmokers
North Suffolk Mental Health Association 25
Not applicableStudy completedNCT01731171
What this trial is testing

Probiotics to Prevent Relapse After Hospitalization for Mania

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Sheppard Pratt Health System 66
Large-scale testing (Phase 3)Study completedNCT04959032
What this trial is testing

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 228
Next Page